MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.

Jin-Zhang SunJin-Hao ZhangJia-Bo LiFeng YuanLu-Qing TongXu-Ya WangLu-Lu ChenXiao-Guang FanYi-Ming ZhangXiao RenChen ZhangSheng-Ping YuXue-Jun Yang

Published in: Disease markers (2021)

Our study suggests that MXRA5 expression is associated with the clinicopathologic features and poor prognosis of gliomas. MXRA5 may play an important role in the immunosuppressive microenvironment of glioma. As a secreted glycoprotein, MXRA5 is a potential circulating biomarker for glioma, deserving further investigation.

Keyphrases

poor prognosis
long non coding rna
risk assessment
human health
climate change